Table 2.
Characteristic | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | P | 95% CI | HR | P | 95% CI | |
CACNA1B (Cav2.2) expression | ||||||
High versus low | 2.701 | <0.001 | 1.797 4.061 | 2.639 | <0.001∗ | 1.699 4.099 |
Gender | ||||||
Male versus female | 1.530 | 0.020 | 1.070 2.188 | 1.230 | 0.339 | 0.804 1.882 |
Age (years) | ||||||
≤60 versus >60 | 1.273 | 0.189 | 0.888 1.826 | |||
Tumor size (cm) | ||||||
≤3 versus >3 | 2.064 | <0.001 | 1.431 2.976 | 1.138 | 0.597 | 0.705 1.836 |
Histopathology grading | ||||||
Adenocarcinoma versus squamous cell carcinoma versus othersa | 0.419 | <0.001 | 0.306 0.574 | 0.572 | 0.004∗ | 0.392 0.837 |
Lymph node metastasis | ||||||
No metastasis versus metastasis | 1.482 | 0.047 | 1.005 2.185 | 0.995 | 0.985 | 0.575 1.721 |
Smoking | ||||||
No smoking versus smoking | 2.237 | 0.001 | 1.365 3.666 | 2.526 | 0.001∗ | 1.440 4.430 |
TNM stage | ||||||
Stage I versus stage II versus stage III | 1.425 | 0.006 | 1.108 1.833 | 1.349 | 0.147 | 0.900 2.024 |
∗ P < 0.05; aothers, adenosquamous carcinoma.